| The Value Line Investment Survey (Part 3 - Ratings & Reports) 2007 J. Susan Ferrara |
| Title | Subject | Authors |
|---|
| 21st Century Ins.(stock price appreciation potential of 21st Century Insurance Group) | Business, general | J. Susan Ferrara |
| Abercrombie.(stock price appreciation potential; Abercrombie & Fitch Co.)(Analyst report) | Business, general | J. Susan Ferrara |
| Alleghany Corp.(stock price appreciation potential) | Business, general | J. Susan Ferrara |
| CDI Corp.(stock price appreciation potential) | Business, general | J. Susan Ferrara |
| Chico's FAS.(stock price appreciation potential)(Analyst report) | Business, general | J. Susan Ferrara |
| Chubb Corp.(stock price appreciation potential) | Business, general | J. Susan Ferrara |
| CIGNA Corp.(stock price appreciation potential) | Business, general | J. Susan Ferrara |
| Cincinnati Fincl.(stock price appreciation potential of Cincinnati Financial Corporation) | Business, general | J. Susan Ferrara |
| Cost Plus, Inc.(stock price appreciation potential)(Analyst report) | Business, general | J. Susan Ferrara |
| Drug industry. | Business, general | George Rho, Sigourney B. Romaine, Milton Schlein, Charles Clark, Jeremy J. Butler, Keith A. Markey, Adam Rosner, J. Susan Ferrara, Frederick L. Harris, Erik A. Antonson, Michael F. Napoli, Douglas G. Maurer |
| Drug industry.(securities analysis as of July 20, 2007)(Industry overview) | Business, general | George Rho, Mario Ferro, Milton Schlein, Charles Clark, Jeremy J. Butler, Keith A. Markey, Adam Rosner, J. Susan Ferrara, Frederick L. Harris, William C. Lewittes |
| Gen-Probe Inc.(stock price appreciation potential) | Business, general | J. Susan Ferrara |
| Gymboree Corp.(stock price appreciation potential)(Analyst report) | Business, general | J. Susan Ferrara |
| HealthExtras, Inc.(stock price appreciation potential) | Business, general | J. Susan Ferrara |
| HealthExtras, Inc.(stock price appreciation potential)(Analyst report) | Business, general | J. Susan Ferrara |
| Healthways, Inc.(stock price appreciation potential) | Business, general | J. Susan Ferrara |
| Heidrick & Strug.(stock price appreciation potential; Heidrick & Struggles International) | Business, general | J. Susan Ferrara |
| Hewitt Assoc. Inc.(stock price appreciation potential; Hewitt Associates Inc.) | Business, general | J. Susan Ferrara |
| Hot Topic, Inc.(stock price appreciation potential)(Analyst report) | Business, general | J. Susan Ferrara |
| Human resource industry.(securities analysis as of July 20, 2007)(Industry overview) | Business, general | David R. Cohen, J. Susan Ferrara, Erik M. Manning |
| Human resources industry.(stock price appreciation potential) | Business, general | J. Susan Ferrara |
| Insurance (property/casualty).(analysis of securities) | Business, general | Alan G. House, J. Susan Ferrara, Randy Shrikishun, Ian Gendler, Jerry W. Gray |
| Isis Pharm, Inc.(stock price appreciation potential of Isis Pharmaceuticals, Inc.) | Business, general | J. Susan Ferrara |
| Kelly Services 'A'.(stock price appreciation potential; Kelly Services Inc. ) | Business, general | J. Susan Ferrara |
| King Pharm.(stock price appreciation potential; King Pharmaceuticals Inc.) | Business, general | J. Susan Ferrara |
| Limited Brands.(stock price appreciation potential)(Analyst report) | Business, general | J. Susan Ferrara |
| Martek Biosciences.(stock price appreciation potential) | Business, general | J. Susan Ferrara |
| MPS Group, Inc.(stock price appreciation potential) | Business, general | J. Susan Ferrara |
| Nu Skin Ent., Inc.(Nu Skin Enterprises, Inc.)(stock price appreciation potential)(Analyst report) | Business, general | J. Susan Ferrara |
| Odyssey HealthCare.(stock price appreciation potential) | Business, general | J. Susan Ferrara |
| Old Republic Int'l.(stock price appreciation potential) | Business, general | J. Susan Ferrara |
| On Assignment.(stock price appreciation potential) | Business, general | J. Susan Ferrara |
| Pacific Sunwear.(stock price appreciation potential; Pacific Sunwear of California Inc.)(Analyst report) | Business, general | J. Susan Ferrara |
| Quiksilver, Inc.(stock price appreciation potential)(Analyst report) | Business, general | J. Susan Ferrara |
| RadioShack Corp.(stock price appreciation potential)(Analyst report) | Business, general | J. Susan Ferrara |
| Retail (special lines) industry.(securities analysis as of August 10, 2007)(Industry overview) | Business, general | Justin Hellman, Robert M. Greene, Craig Sirois, Deborah Y. Fung, Raymond S. Cowen, Noah Goldner, Dylan D. Cathers, Edward Plank, Mario Ferro, Jerome H. Kaplan, J. Susan Ferrara, Charles W. Noh, Andre J. Costanza, Garrett Sussman, Scott Mintz, Paul E.Debbas, Evan I. Blatter, J. Susan Ferrara |
| Retail (special lines) industry.(stock price appreciation potential)(Analyst report) | Business, general | J. Susan Ferrara |
| Robert Half Int'l.(stock price appreciation potential; Robert Half International Inc.) | Business, general | J. Susan Ferrara |
| Sharper Images.(stock price appreciation potential)(Analyst report) | Business, general | J. Susan Ferrara |
| Teva Pharm.(stock price appreciation potential; Teva Pharmaceutical Industries Ltd.) | Business, general | J. Susan Ferrara |
| United Ther.(stock price appreciation potential of United Therapeutics Corp.) | Business, general | J. Susan Ferrara |
| Vertex Pharm, Inc.(stock price appreciation potential of Vertex Pharmaceuticals, Inc.) | Business, general | J. Susan Ferrara |
| XL Cap'l Ltd.(stock price appreciation potential of XL Capital Ltd.) | Business, general | J. Susan Ferrara |
| Zale Corp.(stock price appreciation potential)(Analyst report) | Business, general | J. Susan Ferrara |
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
